20265
ORBO™ 53 gel de sílice activado (20/40) especialmente limpiado, 400/200 mg con filtros de fibra de vidrio
GFF,F,F separators, O.D. × L 7 mm × 100 mm, pkg of 50 ea
Sinónimos:
ORBO™ Activated Silica Gel Tube
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
UNSPSC Code:
47131900
NACRES:
NB.21
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
material
GFF,F,F separators, silica gel
agency
NIOSH 2011,7903, OSHA ID-165SG,ID-174SG
product line
ORBO™
composition
Bed A, 400 mg , Bed B, 200 mg
packaging
pkg of 50 ea
manufacturer/tradename
ORBO™ 53
technique(s)
active air sampling: suitable
O.D. × L
7 mm × 100 mm
matrix
Activated silica gel (specially cleaned)
particle size
20-40 mesh
application(s)
air monitoring
environmental
industrial hygiene
General description
ORBO™ 53 Activated Silica Gel (20/40) specially cleaned, 400/200 mg with Glass Fiber Filters consists of two beds of the same selective adsorbent separated by glass, wool, or foam. The dual-layer or two-bed construction of the tube allows for any sample breakthrough to be captured in the smaller backup bed.
Application
ORBO™ 53 Activated Silica Gel (20/40) specially cleaned, 400/200 mg with Glass Fiber Filters have been used for active sampling of acid gases, specifically formic and acetic acid, and for collecting inorganic acids in cleanroom air.
Legal Information
ORBO is a trademark of Sigma-Aldrich Co. LLC
Clase de almacenamiento
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Application of ion chromatography to the semiconductor industry: I. Measurement of acidic airborne contaminants in cleanrooms.
S Jessie L, et al.
Journal of Chromatography A, 804, 273-278 (1998)
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia